Clinical and microbiological analysis of risk factors for breakthrough bloodstream infection during Tigecycline Therapy

Clinical and microbiological analysis of risk factors for breakthrough bloodstream infection during Tigecycline Therapy

Abstract Background Tigecycline is widely used to treat a variety of bacterial infections despite concerns regarding increased mortality in severe infections. Previous case reports have documented breakthrough bloodstream infections (BSI) during tigecycline therapy. This study aimed to investigate t...

Full description

Saved in:
Bibliographic Details
Main Authors: Sol Jin, So Yun Lim, Yun Woo Lee, Heungsup Sung, Mi-Na Kim, Seongman Bae, Jiwon Jung, Min Jae Kim, Sung-Han Kim, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Eun Hee Song, Yong Pil Chong
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Tigecycline
Breakthrough bacteremia
Risk factors
Breakthrough infection
Online Access:https://doi.org/10.1038/s41598-025-88048-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-88048-7

Similar Items